Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Postoperative Complications × Fondaparinux × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1 Thromboembolism 1 Postoperative Complications 1 Neoplasms 1

Interventions

Wound Closure Techniques 1 World Health Organization oral rehydration solution 1 Tranexamic Acid 1 Tracheostomy 1 Therapeutics 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Ropivacaine 1 Radiotherapy 1 Intermittent Pneumatic Compression Devices 1 Fondaparinux 1 Fibrin Tissue Adhesive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00539942 2017-03-27

Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy

University of Alabama at Birmingham

Phase 3 Terminated

7 enrolled 9 charts

Postoperative Complications, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡